Facebook
Twitter
LinkedIn
ForwardIaPMR Fall Conference
Overview
| Registration |
|---|
There is no cost to attend but registration is requested. You must login or create an account before enrolling in this educational activity. Once you're logged in, click the green "ENTER" button found in the Course Summary box to your right. Your registration will then be confirmed. |
Agenda
| 10 am | Tour of MedPharm 1953 Market Street |
| 12 pm | Lunch and Business Meeting at Des Moines University |
| 1 pm | Cannabinoids in Practice: A Focus on Pain, Spasticity, and Policy Jolene Smith, DO, DABA, DABA-PM
|
| 2 pm | Iowa Medical Cannabidiol Act Owen Parker, MPH
|
| 3 pm | Standards of Practice: Medical Cannabidiol Kent Nebel, JD
|
| 4 pm | Adjourn |
Speakers
Kent Nebel, JD
Interim Executive Director and Director of Legal Affairs, Iowa Board of Medicine
Kent Nebel has been with the Iowa Board of Medicine for 20 years serving as the Director of Legal Affairs and, most recently, the Interim Executive Director. He received his Doctor of Jurisprudence from Drake University, and has many years of legal and leadership experience in the field of medicine.
Owen Parker, MPH
Program Manager, Office of Medical Cannabidiol, Iowa Department of Public Health
Mr. Parker is the Program Manager for the Office of Medical Cannabidiol within the Iowa Department of Public Health. He received his Master of Public Health degree from the University of Iowa College of Public Health. He has spent several years working in operations, compliance and business development for a multi-state cannabis facilities operator and brings a unique combination of education and experience to his current role.
Jolene Smith, DO, DABA, DABA-PM
Pain Medicine Physician, Pain Specialists of Iowa
Disclosures
The following individual(s) have nothing to disclose regarding conflicts with commercial interests:
- Kent Nebel, JD (speaker)
- Owen Parker, MPH (speaker)
- Jacqueline M. Stoken, DO, FAAPMR, FAOCPMR, DABHM, CIME (activity director)
The following individual(s) have conflicts with commercial interests to disclose:
- Jolene Smith, DO, DABA, DABA-PM (speaker) - Dr. Smith discloses that she is a consultant for Boston Scientific and Abbott, and that her spouse is a consultant for MedPharm Iowa.
Location
Des Moines University is located on a 22-acre campus in the heart of Des Moines, Iowa. Just west of downtown on Grand Avenue, the University is located in one of Des Moines' most prestigious neighborhoods. The campus is in a historic neighborhood filled with tree-lined streets and gracious older homes and businesses. Its central location makes it easy to access the rest of the city and outlying communities. The campus is close to the Des Moines International Airport, located on the bus line and just blocks from local shopping and downtown Des Moines.
Travel
CE Credits
Continuing Education Credit
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University
(DMU) and Iowa Academy of Physical Medicine and Rehabilitation. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. - DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 3.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Health Professionals: This live activity is designated for a maximum of 3.0 AMA PRA Category 1 Credit(s)™.
EDUCATIONAL GRANTS
No commercial interest company provided financial support for this continuing education activity.
DISCLOSURE
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 3.00 AMA PRA Category 1 Credits™
- 3.00 AOA Category 2A
- 3.00 CE Contact Hour(s)